Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 May 24;15(5):e39424.
doi: 10.7759/cureus.39424. eCollection 2023 May.

A Case of Syringocystadenocarcinoma Papilliferum: Not Your Usual Suspect

Affiliations
Case Reports

A Case of Syringocystadenocarcinoma Papilliferum: Not Your Usual Suspect

Alena Bashinskaya et al. Cureus. .

Abstract

Syringocystadenocarcinoma papilliferum (SCACP) is an exceptionally rare cutaneous adnexal tumor that is infrequently encountered by clinicians worldwide. The tumor typically appears in the older population, affecting patients in their fifth and sixth decades of life without male or female predominance. Patients frequently present with a variable-sized hyperpigmented ulcerative lesion containing an exudate that has a long-standing course of progression from its benign counterpart, Syringocystadenoma papilliferum (SCAP). Additionally, the clinical presentation and morphology of the neoplasm can be easily confused with a variety of other skin cancers, such as squamous cell carcinoma (SCC), basal cell carcinoma (BCC), cutaneous lymphoma, and cutaneous metastasis. Therefore, histopathology and tissue analysis play an essential role in establishing an accurate diagnosis. However, the lesion is so rare that no definitive diagnostic markers have been established yet. We present a case of SCACP localized to the scalp of the patient. Our case study highlights the presence of specific tumor markers that could potentially serve as objective criteria for diagnosis.

Keywords: adnexal skin tumor; dermatology; nevus sebaceous; scalp lesion; skin histopathology; syringocystadenocarcinoma papilliferum; syringocystadenoma papilliferum.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Ulcerating SCACP lesion on the mid-frontal scalp.
Figure 2
Figure 2. Higher magnification shows papillary architecture and prominent nuclear atypia (H&E. X40).
Figure 3
Figure 3. The neoplastic aggregates (red circle) in the dermis with dense inflammatory cell infiltrate (H&E. X100).

References

    1. Current diagnosis and treatment options for cutaneous adnexal neoplasms with apocrine and eccrine differentiation. Płachta I, Kleibert M, Czarnecka AM, Spałek M, Szumera-Ciećkiewicz A, Rutkowski P. Int J Mol Sci. 2021;22 - PMC - PubMed
    1. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Bell D, Aung P, Prieto VG, Ivan D. Ann Diagn Pathol. 2015;19:381–384. - PubMed
    1. Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases. Zhang Y, Kong YY, Cai X, Shen XX, Kong JC. J Cutan Pathol. 2017;44:538–543. - PubMed
    1. Syringocystadenocarcinoma papilliferum in a fifteen-year-old girl: a case report and review of the literature. Halsey JN, Faith EF, Logan SJ, et al. Case Rep Dermatol Med. 2022;2022:8076649. - PMC - PubMed
    1. Syringocystadenocarcinoma papilliferum: a case report and review of the literature. Lee KG, Choi W, Lim JS, Hahn HJ, Myung KB, Cheong SH. Ann Dermatol. 2019;31:559–562. - PMC - PubMed

Publication types

LinkOut - more resources